ES2199681A1 - Una forma farmaceutica solida para piensos substancialmente granular y no pulverulenta. - Google Patents

Una forma farmaceutica solida para piensos substancialmente granular y no pulverulenta.

Info

Publication number
ES2199681A1
ES2199681A1 ES200201815A ES200201815A ES2199681A1 ES 2199681 A1 ES2199681 A1 ES 2199681A1 ES 200201815 A ES200201815 A ES 200201815A ES 200201815 A ES200201815 A ES 200201815A ES 2199681 A1 ES2199681 A1 ES 2199681A1
Authority
ES
Spain
Prior art keywords
animals
fatty esters
granulated powder
inert core
polyhydroxy alcohols
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES200201815A
Other languages
English (en)
Other versions
ES2199681B1 (es
Inventor
Aran Jordi Prat
Escorihuela Gemma Fernandez
Genis Marta Torras
Puig Joan Marca
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Calier S A Lab
Original Assignee
Calier S A Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Calier S A Lab filed Critical Calier S A Lab
Priority to ES200201815A priority Critical patent/ES2199681B1/es
Publication of ES2199681A1 publication Critical patent/ES2199681A1/es
Application granted granted Critical
Publication of ES2199681B1 publication Critical patent/ES2199681B1/es
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K40/00—Shaping or working-up of animal feeding-stuffs
    • A23K40/10—Shaping or working-up of animal feeding-stuffs by agglomeration; by granulation, e.g. making powders
    • A23K1/002—
    • A23K1/16—
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Husbandry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

"Una forma farmacéutica sólida para piensos substancialmente granular y no pulverulenta". La presente invención se refiere a una forma farmacéutica sólida substancialmente granular y no pulverulenta, destinada a piensos para el tratamiento y prevención de enfermedades o la alimentación de los animales que comprende un núcleo inerte, un recubrimiento basado en ésteres grasos de alcoholes polihidroxílicos junto con al menos un principio activo, y una capa exterior protectora de parafina. Esta forma farmacéutica sólida granular exhibe una mayor estabilidad del producto y una mejor fluidez de vertido, y permite una dosificación más precisa de los principios activos en los piensos para animales.
ES200201815A 2002-08-01 2002-08-01 Una forma farmaceutica solida para piensos substancialmente granular y no pulverulenta. Expired - Fee Related ES2199681B1 (es)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ES200201815A ES2199681B1 (es) 2002-08-01 2002-08-01 Una forma farmaceutica solida para piensos substancialmente granular y no pulverulenta.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES200201815A ES2199681B1 (es) 2002-08-01 2002-08-01 Una forma farmaceutica solida para piensos substancialmente granular y no pulverulenta.

Publications (2)

Publication Number Publication Date
ES2199681A1 true ES2199681A1 (es) 2004-02-16
ES2199681B1 ES2199681B1 (es) 2005-05-01

Family

ID=31897090

Family Applications (1)

Application Number Title Priority Date Filing Date
ES200201815A Expired - Fee Related ES2199681B1 (es) 2002-08-01 2002-08-01 Una forma farmaceutica solida para piensos substancialmente granular y no pulverulenta.

Country Status (1)

Country Link
ES (1) ES2199681B1 (es)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2016043A (en) * 1978-03-08 1979-09-19 Danochemo As Bacteria-containing product for use in animal feeds, and its production
EP0197188A1 (en) * 1985-04-12 1986-10-15 DOX-AL ITALIA S.p.A. Non-dusty blends of meals or flours with additives for use in fodder production
ES2062697T3 (es) * 1989-12-28 1994-12-16 Rhone Poulenc Nutrition Animal Procedimiento para la incorporacion en pellets de principios activos protegidos contra la degradacion en la panza de los rumiantes.
ES2085976T3 (es) * 1990-06-29 1996-06-16 Rhone Poulenc Nutrition Animal Procedimiento para la preparacion de granulados de principios activos por extrusion.

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2016043A (en) * 1978-03-08 1979-09-19 Danochemo As Bacteria-containing product for use in animal feeds, and its production
EP0197188A1 (en) * 1985-04-12 1986-10-15 DOX-AL ITALIA S.p.A. Non-dusty blends of meals or flours with additives for use in fodder production
ES2062697T3 (es) * 1989-12-28 1994-12-16 Rhone Poulenc Nutrition Animal Procedimiento para la incorporacion en pellets de principios activos protegidos contra la degradacion en la panza de los rumiantes.
ES2085976T3 (es) * 1990-06-29 1996-06-16 Rhone Poulenc Nutrition Animal Procedimiento para la preparacion de granulados de principios activos por extrusion.

Also Published As

Publication number Publication date
ES2199681B1 (es) 2005-05-01

Similar Documents

Publication Publication Date Title
WO2005048923A3 (en) Extended release venlafaxine formulation
WO2006035417A3 (en) Dihydropyrimidine microcapsule - formulations
WO2004056337A3 (en) Oral dosage forms with therapeutically active agents in controlled release cores and immediate release gelatin capsule coats
WO2009059701A3 (de) Retardtabletten mit hydromorphon
WO2009117130A3 (en) Extended release forumulation containing a wax
MXPA02000277A (es) Particulas de encubrimiento de textura que contienen un ingrediente activo.
MY169471A (en) Controlled release preparation
ATE512659T1 (de) Tablette mit verzögerter wirkstofffreigabe und bestimmter formgeometrie
AU2003251504A1 (en) Systems and methods for the creation of software packages using layered systems
JP2002511411A5 (es)
GB2402063B (en) Pharmaceutical composition for controlled release of active substances and the manufacturing method thereof
WO2008011169A3 (en) Controlled release formulations and associated methods
GEP20064022B (en) Pharmaceutical formulations comprising oxycodone and naloxone
WO2006015943A3 (en) Extended release pellet formulation containing pramipexole or a pharmaceutically acceptable salt thereof, method for manufacturing the same and use thereof
EP1499300A4 (en) PHARMACEUTICAL FORMULATIONS WITH IMPROVED BIOAVAILABILITY
WO2004093801A3 (en) Pharmaceutical products
WO2004009445A3 (en) Packaging and dispensing of rapid dissolve dosage form
NO20042367L (no) Mikronisert filmdannende pulver omfattende et aktivt stoff
AU2001263264A1 (en) Tablets and methods for modified release of hydrophilic and other active agents
PL1727551T3 (pl) Kompozycja farmaceutyczna zawierająca pochodną benzodiazepiny i inhibitor fuzji białek RSV
PL1727550T3 (pl) Kompozycja farmaceutyczna zawierająca pochodną benzodiazepiny i inhibitor białka fuzyjnego RSV
WO2005009410A3 (en) Pharmaceutical compositions having a swellable coating
WO2005007137A3 (de) Ambroxolhaltige tabletten
AU2001248336A1 (en) Controlled release oral solid forms containing mesalazine as active agent
AU2003214121A1 (en) A system for the controlled release of active ingredients

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 20040216

Kind code of ref document: A1

FD2A Announcement of lapse in spain

Effective date: 20220826